| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/19/1995 | EP0648206A1 Peptidyl derivatives and their use as metalloproteinase inhibitors |
| 04/19/1995 | EP0648126A1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer |
| 04/19/1995 | EP0648125A1 Anti-inflammatory agent |
| 04/19/1995 | EP0648123A1 INHIBITORS OF PROTEIN TYROSINE-PHOSPHATASE -g(a) FOR TREATMENT OF TUMORS. |
| 04/19/1995 | EP0648113A1 Bioadhesive solid mineral oil emulsion |
| 04/19/1995 | EP0570375B1 Novel peptides with anticoagulatory effect |
| 04/19/1995 | EP0541822B1 Novel calcitonin, and production and use thereof |
| 04/19/1995 | EP0527755A4 Improved method for radiolabeling monovalent antibody fragments |
| 04/19/1995 | EP0497915B1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
| 04/19/1995 | EP0455833B1 Amino acid derivative |
| 04/19/1995 | EP0451299B1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 04/19/1995 | EP0436016B1 Chimeric anti-cea antibody |
| 04/19/1995 | EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 04/19/1995 | EP0388466B1 NUCLEIC ACID CODING FOR THE HUMAN ANGIOTENSINE CONVERSION ENZYME (ACE), AND ITS APPLICATIONS PARTICULARLY FOR THE $i(IN VITRO) DIAGNOSIS OF HIGH BLOOD PRESSURE |
| 04/19/1995 | EP0243446B1 Alpha tocopherol-based vesicles |
| 04/19/1995 | CN1101572A Tumor metastasis-suppressing agent and veterinary tumor metastasis-suppressing agent |
| 04/19/1995 | CA2117843A1 Agent for suppressing the motor activity of gastrointestinal tracts |
| 04/18/1995 | US5408041 Multiple elutions with Sepharose, Sephacryl, HPLC; for bone disorders, osteoporosis, Paget*s disease |
| 04/18/1995 | US5408040 Connective tissue growth factor(CTGF) |
| 04/18/1995 | US5408039 Repeated ion exchanging of plasma cryoprecipitate, then affinity chromatography of effluent |
| 04/18/1995 | US5408038 Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides |
| 04/18/1995 | US5407960 For cardiovascualr disorders, pain |
| 04/18/1995 | US5407916 Oligopeptides for use as analgesics or antipsychotic agents |
| 04/18/1995 | US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these |
| 04/18/1995 | US5407914 Pulmonary surfactant protein and related polypeptides |
| 04/18/1995 | US5407913 Method and composition for systemic treatment of tissue injury |
| 04/18/1995 | US5407912 Method of treating bladder cancer with a keyhole limpet hemocyanin composition with enhanced anti-tumor activity |
| 04/18/1995 | US5407911 Contains an azacycloalkane derivative and glycyrrhizic acid as absorption promoter |
| 04/18/1995 | US5407823 Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides |
| 04/18/1995 | US5407805 Monoclonal antibody reactive to various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
| 04/18/1995 | US5407796 Cystic fibrosis mutation cluster |
| 04/18/1995 | US5407673 Plasmin inhibited and stabilized with sodium lauryl sulfate, reactivated on removal |
| 04/18/1995 | US5407672 Enhancing the anti-tumor effect of melphalan with L-amino acid oxidase |
| 04/18/1995 | US5407671 Mixture of fibrinogen, blood coagulation factor xiii, prothrombin, antitrombin, calcium compound and aprotinin |
| 04/18/1995 | US5407670 Comprising polymyxin, bacitracin, neomycin, iobine, and sugar mixture; wounds, burns, lesions, rashes, decubital ulcers; synergistic |
| 04/18/1995 | US5407669 Inproved corneal preservation on storage |
| 04/18/1995 | CA1335255C Low ph pharmaceutical compositions of recombinant beta-interferon |
| 04/16/1995 | CA2133271A1 Methods and compositions for the oral delivery of therapeutic agents |
| 04/16/1995 | CA2108606A1 X-linked adrenoleukodystrophy gene and corresponding protein |
| 04/13/1995 | WO1995009924A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
| 04/13/1995 | WO1995009918A1 Tissue inhibitor metalloproteinase type three (timp-3) |
| 04/13/1995 | WO1995009917A1 Genetically engineered bispecific tetravalent antibodies |
| 04/13/1995 | WO1995009916A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/13/1995 | WO1995009913A1 Human monocyte/macrophage derived metalloproteinase inhibitor |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009908A1 Novel tissue plasminogen activator analog |
| 04/13/1995 | WO1995009873A1 A monoclonal anti-human il-6 receptor antibody |
| 04/13/1995 | WO1995009872A1 Dna encoding prostaglandin receptor ip |
| 04/13/1995 | WO1995009871A1 Novel antitumor peptide |
| 04/13/1995 | WO1995009869A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 04/13/1995 | WO1995009868A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 04/13/1995 | WO1995009867A1 Antifungal compositions |
| 04/13/1995 | WO1995009866A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009865A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009864A1 Novel peptide derivative |
| 04/13/1995 | WO1995009859A1 Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring |
| 04/13/1995 | WO1995009858A1 Dipeptide boronic acid inhibitors of trypsin-like enzymes |
| 04/13/1995 | WO1995009841A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 04/13/1995 | WO1995009838A1 INHIBITORS OF β-AMYLOID PROTEIN PRODUCTION |
| 04/13/1995 | WO1995009657A1 Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995009655A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | WO1995009654A1 Gene therapy of the nervous system |
| 04/13/1995 | WO1995009653A1 Antibodies to cd40 |
| 04/13/1995 | WO1995009652A1 Treatment of autoimmune and inflammatory disorders |
| 04/13/1995 | WO1995009650A1 Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof |
| 04/13/1995 | WO1995009648A1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 04/13/1995 | WO1995009647A1 METHOD OF TREATING SEPTIC SHOCK USING THYMOSIN-α¿1? |
| 04/13/1995 | WO1995009646A1 METHOD OF TREATING SEPTIC SHOCK USING THYMOSIN β¿4? |
| 04/13/1995 | WO1995009645A1 Method of treating septic shock by preventing actin polymerization |
| 04/13/1995 | WO1995009644A1 Medicaments comprising relaxin and their use |
| 04/13/1995 | WO1995009643A1 Endothelin activity inhibitor |
| 04/13/1995 | WO1995009641A1 Using lectins for contraception, prophylaxis and therapy |
| 04/13/1995 | WO1995009639A1 Ocular therapy with homologous macrophages |
| 04/13/1995 | WO1995009638A1 Improvements relating to antibacterial compositions |
| 04/13/1995 | WO1995009634A1 Electrophilic peptide analogs as inhibitors of trypsin-like enzymes |
| 04/13/1995 | WO1995009625A1 Use of amiodarone for the treatment of heart failure |
| 04/13/1995 | WO1995009622A1 Polyunsaturated fatty acids and uses thereof |
| 04/13/1995 | WO1995009620A1 Sulfoximine and sulfodiimine matrix metalloproteinase inhibitors |
| 04/13/1995 | WO1995009611A2 Stable protein: phospholipid compositions and methods |
| 04/13/1995 | WO1995007934A3 Il8 inhibitors |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 04/13/1995 | WO1995005167A3 Treatment of adverse effects associated with administration of extracellular hemoglobin |
| 04/13/1995 | CA2201508A1 Using lectins for contraception, prophylaxis and therapy |
| 04/13/1995 | CA2174311A1 Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring |
| 04/13/1995 | CA2173625A1 Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained |
| 04/13/1995 | CA2173598A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 04/13/1995 | CA2173502A1 Antifungal compositions |
| 04/13/1995 | CA2173495A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | CA2173460A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 04/13/1995 | CA2173356A1 Medicaments comprising relaxin and their use |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2171109A1 Gene therapy of the nervous system |
| 04/13/1995 | CA2169084A1 Improvements relating to antibacterial compositions |
| 04/13/1995 | CA2151261A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/12/1995 | EP0647716A1 Vector comprising viral gene transcribed by ARN polymerase III |
| 04/12/1995 | EP0647656A1 Motilin-like polypeptides that inhibit gastrointestinal motor activity |